Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

NASDAQ:AIRS - Nasdaq - US0094961002 - Common Stock - Currency: USD

1.7  +0.11 (+6.92%)

After market: 1.7 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AIRS. AIRS was compared to 105 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AIRS have multiple concerns. AIRS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AIRS had negative earnings in the past year.
AIRS had a positive operating cash flow in the past year.
In multiple years AIRS reported negative net income over the last 5 years.
In the past 5 years AIRS always reported a positive cash flow from operatings.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.93%, AIRS is doing worse than 64.15% of the companies in the same industry.
AIRS has a Return On Equity (-10.41%) which is in line with its industry peers.
Industry RankSector Rank
ROA -3.93%
ROE -10.41%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Gross Margin, with a value of 64.08%, AIRS belongs to the top of the industry, outperforming 85.85% of the companies in the same industry.
In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIRS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AIRS has more shares outstanding
Compared to 1 year ago, AIRS has a worse debt to assets ratio.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

AIRS has an Altman-Z score of 1.04. This is a bad value and indicates that AIRS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AIRS (1.04) is worse than 68.87% of its industry peers.
AIRS has a Debt/Equity ratio of 0.89. This is a neutral value indicating AIRS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, AIRS is doing worse than 61.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACCN/A
WACC8.6%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

AIRS has a Current Ratio of 0.60. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.60, AIRS is not doing good in the industry: 88.68% of the companies in the same industry are doing better.
AIRS has a Quick Ratio of 0.60. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
AIRS has a Quick ratio of 0.60. This is amonst the worse of the industry: AIRS underperforms 83.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

AIRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -87.50%.
The Revenue has decreased by -7.94% in the past year.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 34.35% on average per year.
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)-7.94%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.71%

3.2 Future

The Earnings Per Share is expected to grow by 21.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, AIRS will show a small growth in Revenue. The Revenue will grow by 4.61% on average per year.
EPS Next Y-20.7%
EPS Next 2Y6.71%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year-9.68%
Revenue Next 2Y-2.37%
Revenue Next 3Y2.16%
Revenue Next 5Y4.61%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIRS. In the last year negative earnings were reported.
Also next year AIRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

AIRS's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.46
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as AIRS's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.71%
EPS Next 3Y21.55%

More info and screens

0

5. Dividend

5.1 Amount

AIRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (4/17/2025, 8:01:28 PM)

After market: 1.7 0 (0%)

1.7

+0.11 (+6.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-14 2025-03-14/bmo
Earnings (Next)05-09 2025-05-09/bmo
Inst Owners23.34%
Inst Owner Change0%
Ins Owners26.92%
Ins Owner Change3.07%
Market Cap99.57M
Analysts74.55
Price Target3.57 (110%)
Short Float %23.86%
Short Ratio14.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-3.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.86%
Min EPS beat(2)-103.64%
Max EPS beat(2)-96.08%
EPS beat(4)1
Avg EPS beat(4)36.16%
Min EPS beat(4)-245.86%
Max EPS beat(4)590.2%
EPS beat(8)2
Avg EPS beat(8)-41.56%
EPS beat(12)3
Avg EPS beat(12)-110.61%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.75%
Min Revenue beat(2)-11.47%
Max Revenue beat(2)-0.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.82%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)-0.03%
Revenue beat(8)2
Avg Revenue beat(8)-2.99%
Revenue beat(12)4
Avg Revenue beat(12)-2.26%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-43.24%
PT rev (3m)-53.33%
EPS NQ rev (1m)-1901.8%
EPS NQ rev (3m)-2300%
EPS NY rev (1m)N/A
EPS NY rev (3m)-632.55%
Revenue NQ rev (1m)-21.03%
Revenue NQ rev (3m)-22.2%
Revenue NY rev (1m)-17.28%
Revenue NY rev (3m)-18.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.55
P/FCF N/A
P/OCF 8.77
P/B 1.26
P/tB N/A
EV/EBITDA 16.46
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.19
OCFY11.4%
SpS3.08
BVpS1.35
TBVpS-0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.93%
ROE -10.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.08%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score3
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 6.98
Cap/Depr 117.83%
Cap/Sales 7.77%
Interest Coverage N/A
Cash Conversion 112.51%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 1.04
F-Score3
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
EPS Next Y-20.7%
EPS Next 2Y6.71%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.94%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.71%
Revenue Next Year-9.68%
Revenue Next 2Y-2.37%
Revenue Next 3Y2.16%
Revenue Next 5Y4.61%
EBIT growth 1Y-119.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.82%
EBIT Next 3Y28.44%
EBIT Next 5YN/A
FCF growth 1Y-118.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.62%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%